Deletion of MLIP (Muscle-enriched A-type Lamin-interacting Protein) Leads to Cardiac Hyperactivation of Akt/Mammalian Target of Rapamycin (mTOR) and Impaired Cardiac Adaptation
Marie‐Elodie Cattin(University of Ottawa), Patrick G. Burgon(Qatar University), Esther Mak(University of Ottawa), Jessica Wang(University of California, Los Angeles), Stephanie Thorn(University of Ottawa), Cassandra Roeske(University of Ottawa), Yibin Wang(Central South University), Jonathan J. Weldrick(University of Ottawa), Aldon J. Lusis(University of California, Los Angeles), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal)
Cited by 34
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393